Airea (AIEA) To Go Ex-Dividend on April 12th

Airea (LON:AIEA) announced a dividend on Wednesday, March 21st, Upcoming.Co.Uk reports. Stockholders of record on Thursday, April 12th will be given a dividend of GBX 5 ($0.07) per share on Wednesday, May 23rd. This represents a dividend yield of 11.11%. The ex-dividend date of this dividend is Thursday, April 12th. This is a boost from Airea’s previous dividend of $1.75. The official announcement can be seen at this link.

Shares of AIEA remained flat at $GBX 59 ($0.83) during mid-day trading on Friday. The stock had a trading volume of 103,467 shares, compared to its average volume of 3,948. Airea has a 12 month low of GBX 28.51 ($0.40) and a 12 month high of GBX 39.50 ($0.55).

COPYRIGHT VIOLATION WARNING: This story was first posted by Ticker Report and is the property of of Ticker Report. If you are reading this story on another site, it was illegally copied and reposted in violation of United States and international trademark & copyright legislation. The original version of this story can be accessed at https://www.tickerreport.com/banking-finance/3338707/airea-aiea-to-go-ex-dividend-on-april-12th.html.

About Airea

AIREA plc manufactures, markets, and distributes floor coverings in the United Kingdom, Ireland, rest of Europe, North America, and internationally. The company offers contract carpets and carpet tiles, including fiber bonded and tufted carpets in sheets and tiles, and barrier and entrance matting products for architects, specifiers, and contractors in the education, leisure, commercial, healthcare, and public sectors under the burmatex brand.

Receive News & Ratings for Airea Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Airea and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Reata Pharmaceuticals  Raised to “Sell” at BidaskClub
Reata Pharmaceuticals Raised to “Sell” at BidaskClub
Territorial Bancorp  Stock Rating Lowered by BidaskClub
Territorial Bancorp Stock Rating Lowered by BidaskClub
VSE  Upgraded at BidaskClub
VSE Upgraded at BidaskClub
Credit Suisse Group Raises Snap  Price Target to $21.00
Credit Suisse Group Raises Snap Price Target to $21.00
Zacks Investment Research Lowers NVR  to Sell
Zacks Investment Research Lowers NVR to Sell
Bristol-Myers Squibb’s  Hold Rating Reiterated at Cowen
Bristol-Myers Squibb’s Hold Rating Reiterated at Cowen


© 2006-2018 Ticker Report. Google+.